Letter
Reply
Jörg J. Goronzy MD,
Jörg J. Goronzy MD
Emory University School of Medicine, Atlanta, GA
Search for more papers by this author Cornelia M. Weyand MD,
Cornelia M. Weyand MD
Emory University School of Medicine, Atlanta, GA
Search for more papers by this author Gene G. Hunder MD,
Gene G. Hunder MD
Mayo Clinic Rochester, MN
Search for more papers by this author Mehrdad Mazlumzadeh MD,
Mehrdad Mazlumzadeh MD
Mayo Clinic, Scottsdale, AZ
Search for more papers by this author
Jörg J. Goronzy MD,
Jörg J. Goronzy MD
Emory University School of Medicine, Atlanta, GA
Search for more papers by this author Cornelia M. Weyand MD,
Cornelia M. Weyand MD
Emory University School of Medicine, Atlanta, GA
Search for more papers by this author Gene G. Hunder MD,
Gene G. Hunder MD
Mayo Clinic Rochester, MN
Search for more papers by this author Mehrdad Mazlumzadeh MD,
Mehrdad Mazlumzadeh MD
Mayo Clinic, Scottsdale, AZ
Search for more papers by this author
First published: 27 April 2007
No abstract is available for this article.
- 1
Chevalet P,
Barrier JH,
Pottier P,
Magadur-Joly G,
Pottier MA,
Hamidou M, et al.
A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients.
J Rheumatol
2000;
27:
1484–91.
- 2
Brack A,
Rittner HL,
Younge BR,
Kaltschmidt C,
Weyand CM,
Goronzy JJ.
Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras.
J Clin Invest
1997;
99:
2842–50.
- 3
Calamia KT,
Hunder GG.
Clinical manifestations of giant cell (temporal) arteritis.
Clini Rheum Dis
1980;
6:
389–403.
- 4
Hunder GG,
Sheps SG,
Allen GL,
Joyce JW.
Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study.
Ann Intern Med
1975;
82:
613–8.
